With D Tablet
Ranitidine Hydrochloride 168mg · Tripotassium Bismuth Dicitrate 200mg +1 more
Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
MFDS item code 201506831 · Approved 2015.09.30
This product's status changed to Approval withdrawn on 2025.01.17. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (ulcers, gastritis, etc.); prevention of Mendelson's syndrome
This drug is effective for various gastrointestinal diseases such as gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also used to prevent ulcers after surgery and to prevent Mendelson's syndrome prior to anesthesia. It helps treat gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). This drug is used to reduce gastric acid secretion, protect the gastric mucosa, and improve symptoms.
Usually, regardless of meals, administer 1 tablet orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drug (NSAID) use or for prevention of gastric and duodenal ulcers during long-term NSAID use. Conditions caused by NSAID use generally heal within 4 weeks, and ulcers generally heal within 8 weeks; however, healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, administer 1 tablet twice daily or 2 tablets once daily at bedtime. However, the dosage may be increased to 2 tablets 4 times daily for patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Begin treatment with an initial dose of 1 tablet 3 times daily and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Once oral administration becomes possible, switch from injection to oral administration and give 1 tablet twice daily. 5) Premedication (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. In this case, it is preferable to also administer 1 tablet on the night before surgery.
This drug should not be used by patients undergoing dialysis or those with poor kidney function. Patients who have had an allergic reaction to this drug or its components, those with a history of acute porphyria, patients who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants and newborns, and patients who need to limit potassium intake should not be given this drug. Patients with poor liver function, a pharmaceutical allergy, the elderly, those with a history of kidney problems, and patients taking non-steroidal anti-inflammatory drugs should use this drug with caution. Especially since it can mask symptoms of gastric cancer, gastric ulcer patients or middle-aged patients who recently present new dyspeptic symptoms should use this drug after confirming the malignancy. Patients with gastric and duodenal ulcers associated with Helicobacter pylori infection require bacterial eradication therapy, and special caution should be taken with critically ill patients or those with hypophosphatemia and dysphagia. Rarely, allergic reactions or shock, skin rashes, blood abnormalities, liver dysfunction, cardiac arrhythmias, digestive symptoms, neurological symptoms, musculoskeletal pain, hair loss, etc., may occur while using this drug. If these symptoms appear, inform medical personnel immediately and discontinue use. Do not use continuously for long periods and observe the treatment progress, using the minimal effective dose. Especially in elderly patients or those with chronic lung disease, diabetes, or weakened immune systems, the risk of pneumonia may increase, so caution should be exercised. If dizziness or drowsiness occurs after taking this drug, avoid driving or operating dangerous machinery. This drug may interact with other medications, so if you are taking any other drugs, be sure to inform your healthcare provider. Particular caution is needed when used in combination with certain anticoagulants, antibiotics, and anticonvulsants, as they may affect the effectiveness or side effects of the medication. Women who are pregnant or breastfeeding are advised not to use this drug, and safety in children has not been established, so its use is generally not recommended. In the event of an overdose, emergency treatments such as vomiting or gastric lavage should be performed, and if necessary, blood dialysis may be used to eliminate the drug. This drug reduces gastric acid secretion, which may promote bacterial growth in the stomach; therefore, regular check-ups, including ocular examinations, are needed with long-term use.
Not everyone experiences these, and they can vary from person to person.
Store this drug in a tightly sealed container to prevent air or moisture from entering. The recommended storage temperature is between 1 degree and 30 degrees Celsius at room temperature. This storage method will help maintain the drug's effectiveness for a long time.
Green rectangular film-coated triple tablet
300 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg · Tripotassium Bismuth Dicitrate 200mg +1 more
Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.